CertusBio secures $4.6 million investment to enhance its biosensor technology for food production efficiency and environmental sustainability, aiming for expansion into North America.
Information on the Target
CertusBio, headquartered in Christchurch, New Zealand, has successfully secured a $4.6 million investment aimed at enhancing its growth both domestically and internationally. The company specializes in innovative biosensor technology designed specifically for food producers, enabling them to enhance production efficiencies while simultaneously reducing the costs associated with wastewater treatment.
Led by CEO Matthew Jones, CertusBio aims to leverage this investment to expand its operations into the North American market. The investment is notable for involving various contributors, including Lincoln Agritech, the original founders of the technology, the Impact Enterprise Fund — New Zealand's first impact investment fund focused on domestic opportunities, NZ Growth Capital Partners via their Aspire NZ Seed Fund, alongside several existing investors.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
New Zealand's food processing industry is a significant contributor to its economy, accounting for a substantial portion of the country's exports. The sector encompasses a diverse range of activities including dairy, meat processing, an
Similar Deals
Pacific Channel → Upstream Medical Technologies
2023
Pacific Channel
invested in
CertusBio
in 2023
in a Seed Stage deal
Disclosed details
Transaction Size: $5M